Stock CMRA COMERA LIFE SCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Comera Life Sciences Holdings, Inc.

Equities

CMRA

US20037C1080

Market Closed - OTC Markets
Other stock markets
 14:30:01 17/05/2024 BST 		5-day change 1st Jan Change
0.0292 USD -4.72% Intraday chart for Comera Life Sciences Holdings, Inc. +38.21% -46.73%
01-30 Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes CI
01-30 Comera Life Sciences Holdings, Inc. Announces Changes to Its Board CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes
Comera Life Sciences Holdings, Inc. Announces Changes to Its Board
Comera Life Sciences Holdings, Inc. Appoints Dorothy Clarke to Board of Directors
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Comera Life Sciences Holdings, Inc. Announces Resignation of Neal Muni, MD as Executive Vice President and Chief Operating Officer
Comera Life Sciences Holdings, Inc. Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Comera Life Sciences Holdings, Inc. Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore(TM) Platform
Comera Life Sciences Holdings, Inc. Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Comera Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
Insider Buy: Comera Life Sciences Holdings
Insider Buy: Comera Life Sciences Holdings
Comera Life Sciences Holdings, Inc. Announces Board Resignations
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Comera Life Sciences Appoints Janice Marie Mccourt as Chief Business Officer
Comera Life Sciences Holdings Says Study Shows SQore Excipient Causes No Local or Systemic Toxicity
Comera Life Sciences Holdings, Inc. Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study
Comera Life Sciences Expands Massachusetts Headquarters
Comera Life Sciences Holdings, Inc. Expands Woburn Operations
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMRA Stock
  4. News Comera Life Sciences Holdings, Inc.
  5. Other languages